Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of symptomatic upper respiratory infection on Technosphere Insulin pharmacokinetics after a meal challenge
2007-002098-30Phase 2Completed
- Sponsor
- MannKind
- Start
- Oct 2007
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Technosphere insulin in diabetes mellitus type 1 (T1D) and type 2 diabetes mellitus (T2DM), sponsored by MannKind. Primary endpoints: Serum FDKP AUC0-4hr and Serum insulin AUC0-4hr. Started Oct 2007; status: completed.
02
Drugs
Technosphere insulin
03
Conditions
diabetes mellitus type 1 (T1D)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-002098-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002098-30.